As of Apr 28
| -0.04 / -1.16%|
The 3 analysts offering 12-month price forecasts for BioTime Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 5.00. The median estimate represents a +76.47% increase from the last price of 3.40.
The current consensus among 3 polled investment analysts is to Buy stock in BioTime Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.